These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17094394)

  • 1. Trastuzumab plus estrogen suppression as salvage treatment in a case of liver failure due to metastatic breast cancer.
    Martoni AA; Bernardi A; Quercia S
    Anticancer Res; 2006; 26(5B):3739-44. PubMed ID: 17094394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.
    Baselga J; Tripathy D; Mendelsohn J; Baughman S; Benz CC; Dantis L; Sklarin NT; Seidman AD; Hudis CA; Moore J; Rosen PP; Twaddell T; Henderson IC; Norton L
    Semin Oncol; 1999 Aug; 26(4 Suppl 12):78-83. PubMed ID: 10482197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trastuzumab monotherapy versus combination therapy for treating recurrent breast cancer: time to progression and survival.
    Nishimura R; Okumura Y; Arima N
    Breast Cancer; 2008; 15(1):57-64. PubMed ID: 18224396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.
    Goldenberg MM
    Clin Ther; 1999 Feb; 21(2):309-18. PubMed ID: 10211534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of breast cancer liver metastases with jaundice responding to trastuzumab monotherapy].
    Ueda H; Nakagawa T; Sato T; Nagahara M; Sugihara K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2068-70. PubMed ID: 23267979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.
    Stemmler HJ; Kahlert S; Siekiera W; Untch M; Heinrich B; Heinemann V
    Breast; 2006 Apr; 15(2):219-25. PubMed ID: 16026983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.
    Burris H; Yardley D; Jones S; Houston G; Broome C; Thompson D; Greco FA; White M; Hainsworth J
    J Clin Oncol; 2004 May; 22(9):1621-9. PubMed ID: 15117984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.
    Stemmler HJ; Stieber P; Lässig D; Heinemann V
    Onkologie; 2005 Feb; 28(2):95-7. PubMed ID: 15692222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab and chemotherapy after the treatment failure of lapatinib for HER2-positive metastatic breast cancer.
    Suzuki Y; Saito Y; Terao M; Terada M; Morioka T; Tsuda B; Okamura T; Niikura N; Tokuda Y
    Tokai J Exp Clin Med; 2010 Dec; 35(4):148-51. PubMed ID: 21319046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.
    Munzone E; Curigliano G; Rocca A; Bonizzi G; Renne G; Goldhirsch A; Nolè F
    Breast Cancer Res; 2006; 8(1):R4. PubMed ID: 16417653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.
    Esteva FJ; Cheli CD; Fritsche H; Fornier M; Slamon D; Thiel RP; Luftner D; Ghani F
    Breast Cancer Res; 2005; 7(4):R436-43. PubMed ID: 15987448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A long survival of a patient with poor performance status who suffered from advanced right breast cancer with multiple lung metastases controlled by trastuzumab as a key drug].
    Fujikawa T; Mukai K; Tanaka A; Abe T; Yoshimoto Y; Tada S; Maekawa H; Shimoike N; Tanaka H; Kawashima T; Yokota T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1009-12. PubMed ID: 22705704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.
    De Maio E; Pacilio C; Gravina A; Morabito A; Di Rella F; Labonia V; Landi G; Nuzzo F; Rossi E; Silvestro P; Botti G; Di Bonito M; Curcio MP; Formichelli F; La Vecchia F; Staiano M; Maurea N; D'Aiuto G; D'Aiuto M; Thomas R; Signoriello G; Perrone F; de Matteis A
    BMC Cancer; 2007 Mar; 7():50. PubMed ID: 17374151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative therapy using trastuzumab and weekly paclitaxel in a stage IIIB inoperable locally advanced HER2- positive breast cancer with complete pathologic response].
    Rai Y; Sagara Y; Ooi Y; Sagara Y; Sagara Y; Baba S; Tamada S; Matsuyama Y; Ando M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):471-3. PubMed ID: 19295274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term survival of a patient with giant liver metastatic breast cancer treated with trastuzumab].
    Okada N; Narita Y; Nanno Y; Shimaguchi M; Imamura K; Inoue R; Nakamura T; Takada M; Kato H; Suzuki O; Ambo Y; Nakamura F; Kishida A; Kashimura N; Matsunami O
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1399-402. PubMed ID: 22996777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of spindle cell carcinoma of the breast including metaplastic lesion with poor prognosis].
    Nakano M; Yamamoto Y; Kawasoe T; Hayashi M; Sueta A; Honda Y; Iyama K; Iwase H
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):1017-9. PubMed ID: 19542728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone receptor status does not affect the clinical benefit of trastuzumab therapy for patients with metastatic breast cancer.
    Brufsky A; Lembersky B; Schiffman K; Lieberman G; Paton VE
    Clin Breast Cancer; 2005 Aug; 6(3):247-52. PubMed ID: 16137436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review.
    Tokuda Y; Suzuki Y; Saito Y; Umemura S
    Breast Cancer; 2009; 16(4):295-300. PubMed ID: 19609647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.